Effect of 5-Minute Movies Shown Via A Mobile Phone App On Risk
Effect of 5-Minute Movies Shown Via A Mobile Phone App On Risk
Effect of 5-Minute Movies Shown Via A Mobile Phone App On Risk
Original Paper
Ayeesha Kamal1*, MD; Adeel Khoja1*, MSc; Bushra Usmani1, MD; Shahvaiz Magsi1, MD; Aresha Malani1,
PharmD; Zahra Peera1, MSc; Saadia Sattar1, MSc; Masood Ahmed Akram 1, PharmD; Sumaira Shahnawaz1, BA;
Maryam Zulfiqar1, MD; Abdul Muqeet2, BSc; Fabiha Zaidi2, BSc; Saleem Sayani2, MSc; Azmina Artani1, MSc;
Iqbal Azam3, MSc; Sarah Saleem3, MSc
1
Aga Khan University, Stroke Services and Research, Karachi, Pakistan
2
Aga Khan Development Network, Digital Health Resource Center, Karachi, Pakistan
3
Aga Khan University, Community Health Sciences, Karachi, Pakistan
*
these authors contributed equally
Corresponding Author:
Ayeesha Kamal, MD
Aga Khan University
Stroke Services and Research
Faculty Office Building, First Floor, Department of Medicine,
Stadium Road Campus
Karachi, 74800
Pakistan
Phone: 92 2134930051 ext 4559
Email: [email protected]
Abstract
Background: Pakistan is the sixth most populous nation in the world and has an estimated 4 million stroke survivors. Most
survivors are taken care of by community-based caregivers, and there are no inpatient rehabilitation facilities.
Objective: The objective of this study was to evaluate the effectiveness and safety of locally designed 5-min movies rolled out
in order of relevance that are thematically delivered in a 3-month program to deliver poststroke education to stroke survivor
and caregiver dyads returning to the community.
Methods: This study was a randomized controlled, outcome assessor–blinded, parallel group, single-center superiority trial in
which participants (stroke survivor-caregiver dyads) with first-ever stroke (both ischemic and hemorrhagic) incidence were
randomized within 48 hours of their stroke into either the video-based education intervention group or the control group. The
video-based education intervention group had health education delivered through short videos that were shown to the
participants and their caregivers at the time of admission, before discharge, and the first and third months of follow-up after
discharge. The control group had standardized care including predischarge education and counseling according to defined
protocols. All participants enrolled in the video education intervention and control groups were followed for 12 months after
discharge for outcome assessment in the outpatient stroke clinics. The primary outcome measures were the proportion of
participants achieving control of blood pressure, blood sugar, and blood cholesterol in the video intervention versus the control
group. Several predefined secondary outcomes were included in this study, of which we report the mortality and functional
disability in this paper. Analysis was by performed using the intention-to-treat principle.
Results: A total of 310 stroke survivors and their caregiver dyads (participant dyads) were recruited over a duration of 6
months. In total, 155 participant dyads were randomized into the intervention and control groups, each. The primary outcome
of control of three major risk factors revealed that at 12 months, there was a greater percentage of participants with a systolic
BP<125 mm Hg (18/54, 33% vs 11/52, 21%; P=.16), diastolic BP<85 mm Hg (44/54, 81% vs 37/52, 71%; P=.21), HbA1c
level<7% (36/55,
65% vs 30/40, 75%; P=.32), and low-density lipoprotein level<100 mg/dL (36/51, 70% vs 30/45, 67%; P=.68) in the
http://mhealth.jmir.org/2020/1/e12113/
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 1 | e12113 | p. 1
RenderX
JMIR MHEALTH AND UHEALTH Kamal et al
intervention
http://mhealth.jmir.org/2020/1/e12113/
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 1 | e12113 | p. 2
RenderX
group than in the control group. The secondary outcome reported is the mortality among the stroke survivors because the
number of stroke-related complications was higher in the control group than in the intervention group (13/155, 8.4% vs 2/155,
1.3%), and this difference was statistically significant (P<.001).
Conclusions: The Movies4Stroke trial failed to achieve its primary specified outcome. However, secondary outcomes that
directly related to survival skills of stroke survivors demonstrated the effectiveness of the video-based intervention on
improving stroke-related mortality and survival without disability.
Trial Registration: ClinicalTrials.gov NCT02202330; https://www.clinicaltrials.gov/ct2/show/NCT02202330
Introduction Objective
Background In this study, we aimed to evaluate the effectiveness and
safety of locally designed 5-min movies rolled out in order of
Stroke is the second leading cause of death globally and the relevance that are thematically delivered in a 3-month
principal cause of acquired disability in adults. About two- program to deliver poststroke education to stroke survivor and
thirds of this burden is endured by the developing world [1]. caregiver dyads returning to the community. We hypothesized
Noncommunicable diseases (NCDs) are the biggest that the absence of trained personnel in the health community
contributors to the rising incidence of stroke. Around 90.5% could be mitigated by actually providing high-quality
of the global stroke burden is attributable to modifiable risk repetitive training using audio visual aids that served as a
factors, including 74.2% attributed to behavioral factors checklist for competency and survival skills to the stroke
(smoking, poor diet, and low physical activity). In addition, survivor and caregiver dyad [7,8].
hypertension, type 2 diabetes mellitus, and coronary artery
disease are important modifiable risk factors for stroke [2]. Methods
Pakistan also has a disproportionate burden of stroke and
NCD risk factors. At present, around 1 in 4 adult Pakistanis Study Design
has hypertension or diabetes, heart disease, or a stroke A randomized controlled, outcome assessor–blinded, parallel
equivalent, with most being unaware of their risks [3]. A local group, single-center superiority trial was conducted to assess
study investigated the prevalence of stroke in Pakistan among the efficacy of mobile phone video–based IT intervention for
adult Pashtun population and reported a prevalence of 4.8%, controlling 3 major risk factors–blood pressure [BP], blood
which is equal to 4 million persons affected in a country with glucose, and cholesterol—among adult stroke survivors.
a population of 180 million [3]. Important secondary outcomes included postdischarge
mortality attributable to stroke and measures of functional
Studies that describe the outcomes of stroke survivors in this
disability. Our detailed protocol has been published separately
setting report that at a median of 5.5 months after discharge,
[9].
12.3% of the patients had died, mostly from recurrent
vascular events or stroke complications. Poor functional Study Site
outcome, defined as Modified Rankin Scale (mRS) score>2, This trial was conducted in the Stroke unit, Neurology Ward,
was seen in 51% of the study participants, and cognitive Aga Khan University Hospital (AKUH), Karachi, Pakistan.
outcomes were poor in 42% of the survivors [4]. AKUH is an internationally recognized tertiary care
In a country of a population of 180 million, roughly only 23 institution, certified by Joint Commission International
centers exist to provide physical medicine or help with Accreditation, and caters to the needs of a large multiethnic
rehabilitation; most have not adopted a multidisciplinary urban population of 18 million people. Stroke care follows
approach toward patients, and none have inpatient services international protocols, with defined order sets and
[5]. Currently, there are no organized home care survival standardized pathways.
programs involving primary caretakers for stroke survivors in
Participants
Pakistan.
The sample population comprised adults (aged>18 years)
Despite these challenges, there is potential to leverage mobile admitted to AKUH with first-ever acute stroke and having a
technology to improve stroke outcomes. Pakistan has designated caregiver, meeting the eligibility criteria, and
widespread mobile connectivity, with a cellular density of giving informed consent.
77% [6]. These infrastructure enablers create distinct
opportunities for mobile health (mHealth). Our rationale was The criteria used while recruiting participants and caregivers at
to leverage information technology (IT)–based mHealth to the initial phase of the selection process are listed below.
provide a solution and knowledge and direct skills to the Eligibility Criteria
survivor and caregiver where the provision of chronic care is
rudimentary. The eligibility criteria have been presented in Textboxes 1 and
2.
Textbox 1. Inclusion criteria.
Adult men and women aged 18 years of age
Residents of Karachi and planning to live in Karachi till the follow-up period
Able to understand Urdu (language of the videos) and the national language
Admitted with first-ever stroke (ischemic or hemorrhagic)
Modified Rankin Scale score4 (mild to moderate disability)
Having at least one vascular risk factor that requires medical intervention
Consenting to participate in the study and for follow-up visits, both stroke survivor and caregiver
Have a designated caregiver at home who is responsible for appointments, follow-up, and overall care and are mobile phone literate, for
example, wife, daughters, daughter-in-law, and husband
Stroke was medically stable, and participant was likely to return to the community after the in-hospital stay (thus actively treated strokes such
as decompressive surgeries, carotid endarterectomy, in-hospital sepsis, and ventilator complications that essentially preclude return to the
community settings were not offered in this chronic care support study).
Serious aphasia, visual hemineglect, short-term memory loss in the stroke survivor precluding understanding, visualization, or retention of the
video material.
Serious aphasia, visual hemineglect, short-term memory loss, dementia in the caregiver precluding understanding, visualization, or retention of
the video material.
Iatrogenic stroke, that is, stroke due to nonatherosclerotic vascular disease and rare causes, for example, carotid dissections, gunshot to neck,
and coronary artery bypass surgery
Stroke survivor/caregiver dyad continued poststroke care in a nursing-assisted, professional, or hospital setting and does not return to the
community after discharge
Serious concurrent medical illnesses such as cancer, renal failure, acute liver disease in past 6 months (that precludes use of statins), and
chronic liver disease, which that exclude the use of stroke preventive medications or require nonstandardized therapy
Any use of off-label, nonguideline medications, because of the stroke survivors’ unique comorbidities, that interferes with medication
compliance to antihypertensive, statins, antiplatelet, and antidiabetic agents
Randomization Process a thorough explanation regarding the nature of the study and
Stroke survivors and their caregivers (dyad) were assigned to the scheduled follow-up visits. A detailed face-to-face
either the intervention or the usual care (control) groups in a interview of stroke survivors and their caregivers was
parallel manner in a ratio of 1:1. Block randomization conducted to gather data on sociodemographic and medical
technique with a fixed block size of 10 was used. A history. A baseline clinical and functional assessment was
computer-generated randomization list was used to randomize performed, after which they were randomly assigned into the
participants into the intervention or control group. The intervention or control group by a trained research officer
randomization center was performed in a secure computer in who was not blinded to the assignment of the intervention.
the clinical trials unit (CTU), and the randomization list was Details regarding the proper functioning of mobile app and its
generated by CTU staff not involved in recruitment, outcome installation were taught to the participants in the intervention
ascertainment, or any aspect of the study. group. A memory card containing Movies4Stroke app was
installed in the participant’s Android phone along with the
Allocation Concealment delivery of the first set of 5-min videos. Videos were shown at
The randomization list was centralized and thus not the time of enrollment into the study, at discharge, and at the
predictable. No one from the research team had any access to first and third month after discharge from the hospital. The
randomization list, randomization envelopes, and block size app was designed to provide access to the videos in a
or code. Envelopes were sealed and opaque, and it was scheduled manner. To maintain contact and follow-up, a
impossible to view the sequence even if held against bright Stroke Helpline number was provided to participants in both
sunlight. Randomization list and opaque envelopes containing the groups. The helpline number was active 24/7, and the
the randomization sequence were always kept inside the person operating at the helpline number was trained to receive
premises of CTU under lock and key. calls with the most frequently anticipated questions and to
answer them accordingly. The operator had access to a stroke
Identification and Enrollment of the Study specialist at all times for support. If the participant was
Participants allocated to the usual care group, he/she was informed about
Informed consent was obtained from eligible participants who the details regarding discharge, follow-up
volunteered to be a part of this study after they were provided
appointments at the clinic, and access to free lab vouchers at messages were sent through a Web-based, programmed,
the 6th and 12th months. open-access software entitled Frontline by a trained IT
Sampling Technique professional.
A purposive sample was selected from adult stroke survivors Intervention Group
admitted into the Stroke unit, Neurology Ward, AKUH, In addition to the usual care, the intervention group at the
Karachi, after the assessment of the eligibility criteria and time of admission received the introductory teaching session
obtaining informed consent. with installation of the app and the first set of 5-min videos on
Technical Part of the Intervention various stroke-related topics as described below. In the first
session, different skills such as swallowing exercises,
The Movies4Stroke app was developed by biomedical and
different rehabilitation exercises, and nasogastric tube feeding
software engineers of Aga Khan Development Network
were taught to the caregivers. The second session was
Electronic Health (eHealth) Resource Center in collaboration
delivered at the time of discharge, which included videos on
with stroke specialists, rehabilitation and swallowing experts,
emergency preparedness, such as cardiopulmonary
and epidemiologists. The intervention was first pilot tested on
resuscitation, seizures, heart attack, and hypoglycemia, while
study team members’ Android cell phones. Any discrepancies
simultaneously discussing and answering any queries the
and bugs were removed from the app. The intervention was
participants had after watching each set of videos. The third
then launched on tablets, specially purchased for showing
session was delivered at the first month of follow-up after
movies to the stroke survivors and their caregivers in clinical
discharge and included videos on frequently used medications
ward settings. Memory chips were also purchased, so that the
by stroke survivors, such as anticoagulants, antihypertensive,
Movies4Stroke app could be transferred into the participants’
and lipid-lowering drugs. The fourth session was delivered at
cell phones.
the third-month of follow-up after discharge and included
Participants in the intervention group were sent weekly videos on secondary stroke prevention (recurrent attack)—
messages twice as a reminder to watch the movies at home. exercise, physical activity, recognition of depression, diet
These modification, and accurate measurement of BP and blood
sugar levels (Figure 1).
Figure 1. Movies4Stroke collage. CPR: cardiopulmonary resuscitation.
Control Group Participants in the control group received the standard of care
that is provided to stroke patients at AKUH. Stroke survivors
were given instructions before discharge regarding diet, the to the videos as mentioned in the protocol [9]. There were
need for rehabilitation, possible complications, and trained research officers to ensure compliance of the
medication use; information booklets were also handed out. A intervention group participants at each video delivery;
multidisciplinary team comprising a neurophysician, stroke moreover, constant SMS reminders were sent to the study
nurse, dietitian, and physiotherapist imparted the information. participants in the intervention group (as a measure of
Verbal instructions were given to stroke survivors and their reinforcement) to watch these thematic movies in a relaxed
caregivers. On the day of discharge, or 24 hours before home environment, and they were also reminded about their
discharge, a discharge coordinator provided the researchers scheduled follow-up visits.
details about the skills learned and ensured that the medical,
social, and rehabilitation requirements were in place before Follow-Up
going out of the hospital. All the study participants were Follow-up visit for each stroke survivor-caregiver dyad was
provided follow-up appointments at the clinic. A detailed organized at 1, 3, 6, 9, and 12 months after discharge in the
written discharge summary was handed over to the caregiver, neurology clinic for outcome ascertainment. Stroke survivors
detailing all aspects of care, including follow-up visit, and their caregivers were given a handout with instructions
medications, lab investigations, and serious alerts. The and basic information about their subsequent follow-up visit.
control group compliance to this standard of care was Caregivers were also explained verbally about the importance
ensured, as all staff follow the abovementioned discharge of their follow-up visit. They were asked to contact the study
protocol and document education. There is designated staff team through the Stroke Helpline for any queries regarding
education and a safe discharge coordinator dedicated for all their health.
admissions at this center. The center at which this study was
performed is an internationally accredited center, and The follow-up rates were maximized by sending SMS
performance and documentation of these quality of care reminders to all the study participants about their respective
standards are a part of the standard of care protocol. This follow-up visits at least a day before their scheduled follow-
standard of care was followed for all participants in the up visit through our Stroke Helpline number and by also
control group because of these regulations that are in place to allowing an approximate 14-day grace period to the stroke
maintain accreditation and auditable quality of care. The survivor and caregiver who were unable to report as per their
control group did not receive the additional visual teaching of scheduled follow-up visit. Those participants who did not
the video-based intervention. This standard of care was appear for their scheduled follow-up visit were contacted
followed for all participants including those who received the through phone or approached through indirect means, such as
video-based intervention. contacting them when they came to the AKUH for any other
clinic or physiotherapy visit or lab investigations. Details of
Compliance During the Administration of the stroke survivors’ visit to the AKUH, other than the neurology
Intervention clinic, was obtained through telecommunication with the
A study officer who was not blinded to the intervention group caregiver or tracking the stroke survivor through the
took several measures to ensure compliance of the participants synchronized electronic medical record system of the AKUH
(Figure 2).
Figure 2. Study flow (enrollment to follow-up).
Participants’ Timeline Of the secondary outcomes, two are discussed in this paper
After recruiting stroke survivors along with their primary with respect to Movies4Stroke trial protocol; others will be
caregivers from the Stroke unit at the AKUH, the participant discussed in the subsequent paper.
dyads were not expected to come in for any additional visits
for the study purpose other than the scheduled 5 follow-up Stroke-Related Mortality Among Stroke
visits at the stroke clinic. Our study started enrolling Survivors Was Ascertained at 12 Months Post
participants from January 19, 2015, and the last participant Discharge
was recruited on May 15, 2015. The last follow-up was Information on mortality among stroke survivors after
completed on June 29, 2016. discharge was ascertained through a precoded and validated
verbal autopsy scale. In addition, we correlated all mortality
Trial Outcomes
with hospital records. Mortality was further categorized as per
The primary outcome measure reported was as follows: the analysis criteria into 3 categories: stroke-related mortality,
control of 3 major risk factors—BP, blood sugar, and lipids— mortality (because of nonstroke complications), and out-of-
measured via standardized methods in the central laboratory hospital mortality.
was ascertained at baseline and 6 and 12 months after
discharge. All the 3 risk factors were assessed, as the Included
proportion of participants achieving BP control (<125/85 mm Mortality after discharge from the AKUH because of stroke-
Hg), blood sugar (glycosylated hemoglobin A1c or related complications was assessed by a review of medical
HbA1c<7%), and blood cholesterol (low-density lipoprotein records, interviews from primary caregivers of the patients,
[LDL] level<100 mg/dL). and the verbal autopsy standard procedure.
Censored Ethics and Human Subject Protection
Mortality after discharge from the hospital because of Written informed consent, in both English and Urdu, was
competing risk, that is, cause of death not related to stroke obtained from all the study participants at the time of
because of, for example, head trauma, gun shot, and cancer, recruitment. The confidentiality and privacy of the
was assessed. participants was maintained by deidentification of the subject
Patients who were alive after 1 year of follow-up after information. Only research staff was authorized entry into the
discharge (censored because of lack of outcome of interest or hospital system on the computers that were used for data
statistical considerations) were assessed. storage. All source documents were maintained in locked files
in locked room. Fingerprint encryption was added to all
Excluded sensitive data, for example, mobile numbers, app logs, and
In-hospital mortality before patients were discharged from the error logs. The Ethical Review Committee (ERC) of Aga
hospital was a result of complications arising from an index Khan University, Karachi (ERC number 2890-Med-ERC-14),
stroke occurring before discharge into the community in a approved the study.
stable state, for example, iatrogenic complications, sepsis, and
progression of index stroke during admission. Results
Moreover, the categorization of all these deaths was further Overall Trial Flow
validated by our team of experts including stroke specialist,
epidemiologist, statisticians, and research supervisor. A total of 310 stroke survivors and their caregiver dyads, ie,
620 individuals (participant dyads), were recruited over a
Stroke Disability and Neurological Deficits Among duration of 6 months. As this clinical trial had a fixed block
Stroke Survivors Was Ascertained at Baseline and 6 design, 155 participant dyads were randomized in each of the
and 12 Months After Discharge intervention and control group (310 in each group). We
A total of 3 different neurological functional assessment tools screened 400 participant dyads to assess eligibility; of these,
were used in this clinical trial, as each of them 50 were not eligible, and 40 participant dyads refused to
captures/measures a different parameter with respect to the participate in the study (30% were excluded; Figure 3). The
functional status of stroke survivors after acute stroke: reasons for exclusions were mRS>4 (n=25), travel plans
(n=15), and non-Karachi residents (n=10). The reasons for
mRS tool is widely used by neuro physicians globally to refusal were mainly the lack of ability to return for follow-up
assess functional disability after acute stroke [10-12]. and personal interest of the stroke survivor or caregiver to
The National Institutes of Health Stroke Scale (NIHSS) participate in the study. We were able to complete information
tool is widely used by neurophysicians globally to on 141 participant dyads in the intervention and 137 in the
objectively quantify the impairment caused by stroke control group at the end of 1-year postdischarge follow-up.
[12,13]. From the intervention group, 11 participant dyads were lost to
The Barthel Index (BI) tool is used globally by health follow-up at 1 year postdischarge and 3 stroke survivors died
care providers to assess the level of dependency among because of in-hospital mortality (before being discharged)
stroke survivors after an acute episode of stroke [12,14]. resulting from inpatient complications from the index stroke,
as compared with 15 participant dyads who were lost to
The abovementioned tools were used to assess the functional follow-up and 3 who died because of in-hospital mortality in
status of stroke survivors at baseline and 6- and 12-month the control group. There was one protocol violation in the
follow-ups. control group that was excluded from the final analysis.
Figure 3. Trial flow diagram. mRS: Modified Rankin Scale.
Baseline Characteristics of the Study Participants intervention group as compared to the control group
Mean age of stroke survivors in the intervention group was (124/155, 80.0%), and more than half of the stroke survivors
60.6 (SD 12.0) years, whereas it was 59.7 (SD 14.3) years in were living in a joint family system (93/155, 60.0%, in the
the control group. The caregivers were relatively younger, intervention group vs 107/155, 69.0%, in the control group).
with the mean age of 38.7 (SD 11.7) years in the intervention Median (interquartile range) number of household members
group and living with stroke survivors was 6 (range: 5-8) in the
39.8 (SD 14) years in the control group. In our trial, most of intervention group as compared with 7 (range: 5-10) in the
the stroke survivors were males (109/155, 70.3%, in the control group. Median household monthly income of the
intervention group vs 100/155, 65.0%, in the control group). stroke survivors was Rs 50,000 (US $416) in both the groups.
More than two-thirds of the stroke survivors in our study had Approximately, four-fifths of our study participants were
more than 5 years of education (114/155, 73.5%, in the Android mobile phone users in the intervention group
intervention group vs 107/155, 69.0%, in the control group), (120/155, 77.4%) as compared with around two-third in the
with 40 of 155 (25.8%) patients being employed in the control group (99/155, 63.8%). Most variables were
intervention group and 39 of 155 (25.1%) in the control uniformly distributed between the two groups and not
group. More than four-fifths of our study participants were statistically significant at baseline (refer to Table 1).
married (134/155, 86.5%) in the
Table 1. Baseline characteristics of study participants according to their group allocation (310 participant dyads)
b
6-month results (N=208) .61
<125 36 (50.0) 36 (50.0) 0.91 (0.62-1.32)
>125 73 (54.0) 63 (46.0) 0.91 (0.62-1.32)
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=109) and control group (n=99).
c
12-month results: intervention group (n=54) and control group (n=52).
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=109) and control group (n=99).
c
12-month results: intervention group (n=54) and control group (n=52).
a .03
Baseline results (N=310)
<7 85 (45.0) 105 (55.0) 0.81 (0.68-0.98)
>7 70 (58.0) 50 (42.0) 0.81 (0.68-0.98)
b
6-month results (N=196) .47
<7 81 (52.0) 74 (48.0) 0.95 (0.82-1.10)
>7 24 (58.0) 17 (42.0) 0.95 (0.82-1.10)
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=105) and control group (n=91).
c
12-month results: intervention group (n=55) and control group (n=40).
b
6-month results (N=196) .33
<100 73 (57.0) 56 (43.0) 1.10 (0.90-1.36)
>100 33 (49.0) 34 (51.0) 1.10 (0.90-1.36)
c
12-month results (N=96) .68
<100 36 (55.0) 30 (45.0) 1.06 (0.81-1.39)
>100 15 (50.0) 15 (50.0) 1.06 (0.81-1.39)
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=106) and control group (n=90).
c
12-month results: intervention group (n=51) and control group (n=45).
Change in Functional Status (Disability and higher percentage of stroke survivors with moderate to severe
Severity) Among Stroke Survivors disability were present in the intervention group than in the
control group (24/135, 17.8% vs 18/129, 14.0%; OR 1.28,
Modified Rankin Scale
95% CI 0.65-2.55). However, at 12 months, a higher
Table 7 and Figures 5 and 6 show that at baseline, as assessed percentage of stroke survivors had minimal to no disability in
by mRS, a higher percentage of stroke survivors with the intervention group than in the control group (91/128,
moderate to severe disability were present in the intervention 71.1% vs 71/120, 59.2%). At 12 months postdischarge, NNT
group than in the control group (46/155, 29.7% vs 36/155, was 9, as assessed by the mRS. This meant that we needed to
23.2%; odds ratio [OR] 1.18, 95% CI 0.58-2.39). Similarly, show Movies4Stroke to 9 stroke survivors to achieve minimal
at 6 months, a to no disability caused by stroke after a year of follow-up.
Table 7. Modified Rankin Scale.
Modified Rankin Scale score
Intervention group, n (%) Control group, n (%) Odds ratio (95% CI) P value (overall)
a .40
Baseline results (N=310)
Figure 5. Functional status of stroke survivors—6 months. NIHSS: National Institutes of Health Stroke Scale.
Figure 6. Functional status of stroke survivors—baseline and 12 months assessment (comparison).
National Institutes of Health Stroke Scale 25/129, 19.4%; OR 0.98, 95% CI 0.50-1.92). At 12 months, a
Table 8 and Figures 5 and 6 show that at baseline, as assessed higher percentage of stroke survivors had minimal to no
by the NIHSS, a higher percentage of stroke survivors had impairment caused by stroke in the intervention group than in
severe impairment caused by stroke in the control group than the control group (65/128, 50.8% vs 55/120, 45.8%). At 12
in the intervention group (72/155, 46.4% vs 61/155, 39.4%; months postdischarge, NNT was 20 as per the NIHSS
OR 0.82, 95% CI 0.39-1.74). At 6 months, a smaller assessment. This meant that we needed to show
percentage of stroke survivors had severe impairment caused Movies4Stroke to 20 stroke survivors to have minimal to no
by stroke in the intervention group than in the control group disability caused by stroke after a year of follow-up.
(23/135, 17.0% vs
Table 8. National Institutes of Health Stroke Scale.
National Institutes of
Health Stroke Scale score Intervention group, n (%) Control group, n (%) Odds ratio (95% CI) P value
(overall)
a
Baseline results (N=310) .52
0-1
18 (11.6) 17 (11.0) Reference
2-8
76 (49.0) 66 (42.6) 1.09 (0.51-2.28)
>9
61 (39.4) 72 (46.4) 0.82 (0.39-1.74)
b
6-month results (N=264) .08
0-1 58 (43.0) 62 (48.0) Reference
2-8 54 (40.0) 38 (29.5) 1.52 (0.88-2.63)
>9 23 (17.0) 25 (19.4) 0.98 (0.50-1.92)
Death 0 (0.0) 4 (3.1)
—c
d
12-month results (N=248) .73
0-1 65 (50.8) 55 (45.8) Reference
2-8 42 (32.8) 44 (36.7) 0.81 (0.46-1.41)
>9 21 (16.4) 21 (17.5) 0.85 (0.42-1.71)
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=135) and control group (n=129).
c
Odds ratio with their 95% CI could not be estimated because of the empty cell count in the intervention group.
d
12-month results: intervention group (n=128) and control group (n=120).
a
Baseline: intervention group (n=155) and control group (n=155).
b
6-month results: intervention group (n=135) and control group (n=129).
c
Odds ratio with their 95% CI could not be estimated because of the empty cell count in the intervention group.
d
12-month results: intervention group (n=128) and control group (n=120).
usage patterns at home, we remotely monitored the access and however, most stroke survivors were on different schedules for
use of our app that had been installed in the mobile phone. follow-up visits and rehabilitation times, and so, we expected
Early results show that the rehabilitation and tube feeding less contamination than in areas where a lot of time is spent
videos were the highly accessed videos at home. These together by families.
analyses are still ongoing.
Trial Limitations
The major limitation of our clinical trial is that it is a single-
center study, chosen because of the fact that this site provided
a standard of care that is algorithmic and replicable; thus,
results generated can be attributed to the effect of
intervention. In this study, we reported its efficacy, but the
performance and potential effect size in different sites may be
variable and potentially be more effective, given the usual
care standards in even more resource-strapped comparative
health systems, for example, the government sector, and thus,
external validity is limited. Furthermore, those with more
severe stroke or better health access because of
socioeconomic status are more likely to visit the health
systems and volunteer to participate in an educational training
intervention, thus limiting direct external validity. We would
definitely include nonresponse analysis in futures studies to
further identify characteristics of those most likely to adopt
the intervention. Another significant limitation is of
contamination bias in an educational intervention. Care was
taken to avoid contamination of the nonintervention group
with the intervention. To ensure this, videos were shown in a
separate room and not at the bedside. Given the fact that
families share information, contamination was possible;
Obviously, it is an inherent limitation of an educational interventions are safe and feasible, despite their complexity.
intervention that blinding of participants is not possible. This Our results demonstrate the key importance of health theory
intervention in a study setting required human resources in in designing these complex health interventions for
terms of a study officer and IT back up, development replicability and informing further interventions.
required human resource, and deployment required at least Interventions that target compliance must have repetitive
three staff in a study setting. To predict feasibility, we need reminders for nonintentional adherence, and those that target
to further analyze cost-effectiveness and realistic compliance knowledge and skills transfer must have the capacity to repeat
in a clinical setting with the current patient volumes, so this and bolster confidence as well as provide the user the
limits directly recommending applicability. This study has opportunity to model themselves from the materials taught,
collected data on cost-effectiveness, which is under analysis despite the lack of literacy skills to be safe. Complex
at this time. interventions targeting these settings need to have a design
theory in place to deliver both these aspects to be effective.
Way Forward
In conclusion, we demonstrate the potential of mHealth Please refer to Consolidated Standards of Reporting Trials-
interventions to save lives and reduce disability in low- to eHealth checklist for details regarding this Movies4Stroke trial
middle-income country settings; we also show that these [42].
Acknowledgments
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper. The
content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty
International Center (National Institutes of Health or NIH), National Institute of Neurological Disorders and Stroke (NIH), and
University Research Council of Aga Khan University.
Conflicts of Interest
None declared.
Multimedia Appendix 1
Detailed Mortality Analysis.
[DOCX File , 24 KB-Multimedia Appendix 1]
Multimedia Appendix 2
Non-pharmacological interventions targeting stroke survivors and their caregivers.
[DOCX File , 18 KB-Multimedia Appendix 2]
Multimedia Appendix 3
Analysis of Lost to Follow Up and Mortality.
[DOCX File , 14 KB-Multimedia Appendix 3]
Multimedia Appendix 4
CONSORT-EHEALTH checklist V1.6.1.
[PDF File (Adobe PDF File), 2557 KB-Multimedia Appendix 4]
References
1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality
reported in 56 population-based studies: a systematic review. Lancet Neurol 2009 Apr;8(4):355-369. [doi:
10.1016/S1474-4422(09)70025-0] [Medline: 19233729]
2. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, Global Burden of Diseases‚ Injuries and Risk
Factors Study 2013 and Stroke Experts Writing Group. Global burden of stroke and risk factors in 188 countries, during
1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 2016 Aug;15(9):913-
924. [doi: 10.1016/S1474-4422(16)30073-4] [Medline: 27291521]
3. Jafar TH. Blood pressure, diabetes, and increased dietary salt associated with stroke--results from a community-based
study in Pakistan. J Hum Hypertens 2006 Jan;20(1):83-85. [doi: 10.1038/sj.jhh.1001929] [Medline: 16151442]
4. Khan M, Ahmed B, Ahmed M, Najeeb M, Raza E, Khan F, et al. Functional, cognitive and psychological outcomes,
and recurrent vascular events in Pakistani stroke survivors: a cross sectional study. BMC Res Notes 2012 Feb 9;5:89
[FREE Full text] [doi: 10.1186/1756-0500-5-89] [Medline: 22321339]
5. Rathore FA, New PW, Iftikhar A. A report on disability and rehabilitation medicine in Pakistan: past, present, and
future directions. Arch Phys Med Rehabil 2011 Jan;92(1):161-166. [doi: 10.1016/j.apmr.2010.10.004] [Medline:
21187218]
6. Liu G, Liu X, Li H, Du Q, Wang F. Optical coherence tomographic analysis of retina in retinitis pigmentosa patients.
Ophthalmic Res 2016;56(3):111-122 [FREE Full text] [doi: 10.1159/000445063] [Medline: 27352292]
7. Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ
Monogr 1974;2(4):336-353. [doi: 10.1177/109019817400200404]
8. Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health 1998;13(4):623-649.
[doi: 10.1080/08870449808407422]
9. Kamal AK, Khoja A, Usmani B, Muqeet A, Zaidi F, Ahmed M, et al. Translating knowledge for action against stroke--
using 5-minute videos for stroke survivors and caregivers to improve post-stroke outcomes: study protocol for a
randomized controlled trial (Movies4Stroke). Trials 2016 Jan 27;17:52 [FREE Full text] [doi: 10.1186/s13063-016-
1175-x] [Medline: 26818913]
10. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988 Dec;19(12):1497-1500.
[doi: 10.1161/01.str.19.12.1497] [Medline: 3201508]
11. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of
handicap in stroke patients. Stroke 1988 May;19(5):604-607. [doi: 10.1161/01.str.19.5.604] [Medline: 3363593]
12. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006;5(7):603-612. [doi:
10.1016/s1474-4422(06)70495-1]
13. Lyden P, Claesson L, Havstad S, Ashwood T, Lu M. Factor analysis of the National Institutes of Health Stroke Scale
in patients with large strokes. Arch Neurol 2004 Nov;61(11):1677-1680. [doi: 10.1001/archneur.61.11.1677]
[Medline: 15534178]
14. Schiemanck SK, Post MW, Witkamp TD, Kappelle LJ, Prevo AJ. Relationship between ischemic lesion volume and
functional status in the 2nd week after middle cerebral artery stroke. Neurorehabil Neural Repair 2005 Jun;19(2):133-
138. [doi: 10.1177/154596830501900207] [Medline: 15883357]
15. ATTEND Collaborative Group. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled
trial. Lancet 2017 Aug 5;390(10094):588-599. [doi: 10.1016/S0140-6736(17)31447-2] [Medline: 28666682]
16. Forster A, Dickerson J, Young J, Patel A, Kalra L, Nixon J, TRACS Trial Collaboration. A structured training
programme for caregivers of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-
effectiveness analysis. Lancet 2013 Dec 21;382(9910):2069-2076. [doi: 10.1016/S0140-6736(13)61603-7] [Medline:
24054816]
17. Markle-Reid M, Orridge C, Weir R, Browne G, Gafni A, Lewis M, et al. Interprofessional stroke rehabilitation for
stroke survivors using home care. Can J Neurol Sci 2011 Mar;38(2):317-334. [doi: 10.1017/s0317167100011537]
[Medline: 21320840]
18. Cameron JI, Naglie G, Green TL, Gignac MA, Bayley M, Huijbregts M, et al. A feasibility and pilot randomized
controlled trial of the 'Timing it Right Stroke Family Support Program'. Clin Rehabil 2015 Nov;29(11):1129-1140. [doi:
10.1177/0269215514564897] [Medline: 25552525]
19. Legg LA, Quinn TJ, Mahmood F, Weir CJ, Tierney J, Stott D, et al. Non-pharmacological interventions for caregivers
of stroke survivors. Cochrane Database Syst Rev 2011 Oct 5(10):CD008179. [doi: 10.1002/14651858.CD008179.pub2]
[Medline: 21975778]
20. Chumbler NR, Li X, Quigley P, Morey MC, Rose D, Griffiths P, et al. A randomized controlled trial on Stroke
telerehabilitation: The effects on falls self-efficacy and satisfaction with care. J Telemed Telecare 2015;21(3):139-
143. [doi: 10.1177/1357633x15571995]
21. Mackay-Lyons M, Thornton M, Ruggles T, Che M. Non-pharmacological interventions for preventing secondary
vascular events after stroke or transient ischemic attack. Cochrane Database Syst Rev 2013(3):CD008656. [doi:
10.1002/14651858.CD008656.pub2] [Medline: 23543566]
22. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ
Q 1988;15(2):175-183. [doi: 10.1177/109019818801500203] [Medline: 3378902]
23. Sharma M, Romas JA. Theoretical Foundations of Health Education and Health Promotion. Burlington, Massachusetts:
Jones & Bartlett Publishers; 2011.
24. Lundy YD. Abstract T P286: telephone support program promotes stroke survivor knowledge, self-care, and
satisfaction. Stroke 2015;46(Suppl 1):ATP286 [FREE Full text]
25. Kitson AL. The need for systems change: reflections on knowledge translation and organizational change. J Adv Nurs
2009 Jan;65(1):217-228. [doi: 10.1111/j.1365-2648.2008.04864.x] [Medline: 19032518]
26. Denny MC, Vahidy F, Vu KY, Sharrief AZ, Savitz SI. Video-based educational intervention associated with
improved stroke literacy, self-efficacy, and patient satisfaction. PLoS One 2017;12(3):e0171952 [FREE Full text]
[doi: 10.1371/journal.pone.0171952] [Medline: 28333925]
27. Molloy GJ, Messerli-Bürgy N, Hutton G, Wikman A, Perkins-Porras L, Steptoe A. Intentional and unintentional
non-adherence to medications following an acute coronary syndrome: a longitudinal study. J Psychosom Res 2014
May;76(5):430-432 [FREE Full text] [doi: 10.1016/j.jpsychores.2014.02.007] [Medline: 24745787]
28. Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on
risk factor modification in patients with coronary heart disease: a randomized clinical trial. J Am Med Assoc
2015;314(12):1255-1263. [doi: 10.1001/jama.2015.10945] [Medline: 26393848]
29. Schmidt H, Barnhill A. Equity and noncommunicable disease reduction under the sustainable development goals.
PLoS Med 2015 Sep;12(9):e1001872 [FREE Full text] [doi: 10.1371/journal.pmed.1001872] [Medline: 26349050]
30. Dalal P, Bhattacharjee M, Vairale J, Bhat P. UN millennium development goals: Can we halt the stroke epidemic in
India? Ann Indian Acad Neurol 2007;10(3):130. [doi: 10.4103/0972-2327.34791]
31. Janus-Laszuk B, Mirowska-Guzel D, Sarzynska-Dlugosz I, Czlonkowska A. Effect of medical complications on
the after-stroke rehabilitation outcome. NeuroRehabil 2017;40(2):223-232. [doi: 10.3233/nre-161407]
32. Domka E, Myjkowska E, Kwolek A. [Incidence of neuromedical complications during rehabilitation after stroke].
Neurol Neurochir Pol 2005;39(4):300-309. [Medline: 16096935]
33. Hochbaum G, Rosenstock I. United States Public Health Service. Kegels S: Health belief model URL:
https://academia. edu/
34. Green EC, Murphy E. Wiley Online Library. 2014. Health Belief Model URL:
https://onlinelibrary.wiley.com/doi/abs/ 10.1002/9781118410868.wbehibs410 [accessed 2019-11-04]
35. Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug
trials. Neuropharmacol 2000;39(5):835-841. [doi: 10.1016/s0028-3908(00)00003-4]
36. Barzel A, Ketels G, Stark A, Tetzlaff B, Daubmann A, Wegscheider K, et al. Home-based constraint-induced movement
therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.
Lancet Neurol 2015 Sep;14(9):893-902. [doi: 10.1016/S1474-4422(15)00147-7] [Medline: 26231624]
37. Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, American Heart Association Stroke Council‚ Council
on Cardiovascular and Stroke Nursing‚ Council on Clinical Cardiology‚Council on Quality of Care and Outcomes
Research. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the
American Heart Association/American Stroke Association. Stroke 2016 Jun;47(6):e98-169. [doi:
10.1161/STR.0000000000000098] [Medline: 27145936]
38. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Lancet NCD Action Group, NCD Alliance.
Priority actions for the non-communicable disease crisis. Lancet 2011 Apr 23;377(9775):1438-1447. [doi:
10.1016/S0140-6736(11)60393-0] [Medline: 21474174]
39. Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, Lancet NCD Action Group. Embedding
non-communicable diseases in the post-2015 development agenda. Lancet 2013 Feb 16;381(9866):566-574.
[doi: 10.1016/S0140-6736(12)61806-6] [Medline: 23410606]
40. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to
randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008 Feb 19;148(4):295-
309. [doi: 10.7326/0003-4819-148-4-200802190-00008] [Medline: 18283207]
41. Chan A, Tetzlaff J, Altman D, Laupacis A, Gøtzsche PC, Krleža-Jeri K, et al. SPIRIT 2013 statement: defining standard
protocol items for clinical trials. Ann Intern Med 2013 Feb 5;158(3):200-207 [FREE Full text] [doi:
10.7326/0003-4819-158-3-201302050-00583] [Medline: 23295957]
42. Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of
Web-based and mobile health interventions. J Med Internet Res 2011 Dec 31;13(4):e126 [FREE Full text] [doi:
10.2196/jmir.1923] [Medline: 22209829]
Abbreviations
AKUH: Aga Khan University Hospital
ARR: absolute risk reduction
BI: Barthel Index
BP: blood pressure
CTU: clinical trials unit
eHealth: electronic health
ERC: Ethical Review Committee
HbA1c: glycosylated hemoglobin A1c
IT: information technology
LDL: low-density lipoprotein
mHealth: mobile health
mRS: Modified Rankin Scale
NCD: noncommunicable disease
NIHSS: National Institutes of Health Stroke Scale
NNT: number needed to treat
OR: odds ratio
RR: risk ratio
Edited by G Eysenbach; submitted 05.09.18; peer-reviewed by B Davis, J Wang; comments to author 07.01.19; revised version
received 01.03.19; accepted 19.07.19; published 28.01.20
Please cite as:
Kamal A, Khoja A, Usmani B, Magsi S, Malani A, Peera Z, Sattar S, Ahmed Akram M, Shahnawaz S, Zulfiqar M, Muqeet A, Zaidi
F, Sayani S, Artani A, Azam I, Saleem S
Effect of 5-Minute Movies Shown via a Mobile Phone App on Risk Factors and Mortality After Stroke in a Low- to Middle-Income
Country: Randomized Controlled Trial for the Stroke Caregiver Dyad Education Intervention (Movies4Stroke)
JMIR Mhealth Uhealth 2020;8(1):e12113
URL: http://mhealth.jmir.org/2020/1/e12113/
doi: 10.2196/12113
PMID:
©Ayeesha Kamal, Adeel Khoja, Bushra Usmani, Shahvaiz Magsi, Aresha Malani, Zahra Peera, Saadia Sattar, Masood Ahmed
Akram, Sumaira Shahnawaz, Maryam Zulfiqar, Abdul Muqeet, Fabiha Zaidi, Saleem Sayani, Azmina Artani, Iqbal Azam,
Sarah Saleem. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 28.01.2020. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic
information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must
be included.